{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10611462", "DateCompleted": {"Year": "2000", "Month": "02", "Day": "11"}, "DateRevised": {"Year": "2019", "Month": "06", "Day": "24"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0014-2999", "JournalIssue": {"Volume": "386", "Issue": "1", "PubDate": {"Year": "1999", "Month": "Dec", "Day": "10"}}, "Title": "European journal of pharmacology", "ISOAbbreviation": "Eur J Pharmacol"}, "ArticleTitle": "Dioclein, a new nitric oxide- and endothelium-dependent vasodilator flavonoid.", "Pagination": {"StartPage": "41", "EndPage": "46", "MedlinePgn": "41-6"}, "Abstract": {"AbstractText": ["In the present work, the vasorelaxant effect of dioclein, a new flavonoid isolated from Dioclea grandiflora (Leguminoseae), was investigated in the rat aorta. Dioclein induced a concentration-dependent relaxation in vessels pre-contracted with phenylephrine (IC(50)=1.3+/-0.3 microM), a response which was abolished after endothelium removal. Neither indomethacin (10 microM), an inhibitor of cyclo-oxygenase, nor atropine (1 microM), an antagonist of muscarinic receptors, modified the effect of dioclein. Dioclein (30 microM) induced a significant increase in guanosine 3':5'-cyclic monophosphate (cyclic GMP) levels in aortic rings with endothelium. The nitric oxide (NO) synthase inhibitor, N(G)-nitro-L-arginine-methyl-ester (L-NAME, 300 microM), strongly inhibited or abolished the relaxing effect and rise in cyclic GMP levels induced by dioclein. Furthermore, dioclein (30 microM) had no effect on the endothelium-independent relaxation produced by the NO donor, 3-morpholino-sydnonimine (SIN-1), while superoxide dismutase (100 U ml(-1)) significantly potentiated it. These results indicate that, in the rat aorta, dioclein induces a NO- and endothelium-dependent vasorelaxant effect, which is associated with cyclic GMP elevation. This vasorelaxation likely results from enhanced synthesis of NO rather than enhanced biological activity of NO."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Laborat\u00f3rio de Hipertens\u00e3o, Departamento de Fisiologia e Biof\u00edsica, Universidade Federal de Minas Gerais, 31270-901, Belo Horizonte, Brazil."}], "Identifier": [], "LastName": "Lemos", "ForeName": "V S", "Initials": "VS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Freitas", "ForeName": "M R", "Initials": "MR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Muller", "ForeName": "B", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lino", "ForeName": "Y D", "Initials": "YD"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Queiroga", "ForeName": "C E", "Initials": "CE"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "C\u00f4rtes", "ForeName": "S F", "Initials": "SF"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Eur J Pharmacol", "NlmUniqueID": "1254354", "ISSNLinking": "0014-2999"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Flavanones"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Vasoconstrictor Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Vasodilator Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "dioclein"}, {"RegistryNumber": "1WS297W6MV", "NameOfSubstance": "Phenylephrine"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "5O5U71P6VQ", "NameOfSubstance": "linsidomine"}, {"RegistryNumber": "D46583G77X", "NameOfSubstance": "Molsidomine"}, {"RegistryNumber": "H2D2X058MU", "NameOfSubstance": "Cyclic GMP"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Aorta, Thoracic"}, {"QualifierName": [], "DescriptorName": "Brazil"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclic GMP"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Endothelium, Vascular"}, {"QualifierName": [], "DescriptorName": "Flavanones"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Molsidomine"}, {"QualifierName": ["drug effects"], "DescriptorName": "Muscle Relaxation"}, {"QualifierName": ["physiology"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Phenylephrine"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Roots"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vasoconstrictor Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vasodilator Agents"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1999", "Month": "12", "Day": "28", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "2", "Day": "19", "Hour": "9", "Minute": "0"}, {"Year": "1999", "Month": "12", "Day": "28", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10611462", "10.1016/s0014-2999(99)00747-5", "S0014-2999(99)00747-5"]}}], "PubmedBookArticle": []}